FDA Recall: J&J MedTech/CERENOVUS CEREPAK Detachable Coil System Removed Due to High Failure-to-Detach Rate

Johnson & Johnson's MedTech division, operating through its CERENOVUS Inc. subsidiary, has initiated a removal of its CEREPAK Detachable Coil System from the market. The action is being taken in response to a higher-than-expected rate of device failure, specifically a failure of the coil to detach from its delivery system as intended. The CEREPAK system is a neurovascular embolization device used in minimally invasive procedures, often for treating brain aneurysms. A failure to detach during a procedure presents a significant patient safety risk, potentially requiring complex surgical intervention to retrieve the undetached coil, prolonging procedure time, and increasing the risk of complications such as vessel damage, thrombosis, or stroke. The recall/removal notice was disseminated via the FDA's MedWatch safety alert system, indicating regulatory oversight of the action. The specific root cause of the increased detachment failure rate has not been publicly detailed in the initial alert. Healthcare facilities and providers are instructed to cease using the affected devices immediately and follow the firm's instructions for returning or disposing of the product. This action highlights ongoing quality control and performance monitoring challenges within the complex medical device supply chain, particularly for high-risk implantable and procedural components.